|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
$105,930
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-03
|
$455,870
|
$227,935
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Initiation of DNA Replication in Mammalian Cells
|
ZIA BC 010411
|
$1,096,129
|
$164,419
|
Aladjem, Mirit
|
CCR (NCI)
|
|
Targeting transducin Beta-like protein 1 in mantle cell lymphoma
|
1K08CA226352-01
|
$227,046
|
$74,925
|
ALINARI, LAPO
|
OHIO STATE UNIVERSITY
|
|
Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors
|
5R21CA213114-02
|
$217,282
|
$217,282
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Immune cell control of ovarian cancer
|
ZIA BC 011775
|
$288,423
|
$57,685
|
Annunziata, Christina
|
CCR (NCI)
|
|
Role of the Long Non-coding RNA PVT1 in Cancer
|
5R01CA200643-03
|
$446,063
|
$446,063
|
BAGCHI, ANINDYA
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Histone Methyltransferases as a Target for Lung Cancer Prevention
|
5R01CA183296-05
|
$731,519
|
$365,760
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-18
|
$672,442
|
$221,906
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$584,022
|
$584,022
|
Beyer, Rachel
|
CCR (NCI)
|
|
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
|
5R21CA216678-02
|
$212,063
|
$106,032
|
BRADLEY, LINDA
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas
|
5P01CA069246-21
|
$1,316,832
|
$579,406
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-03
|
$418,127
|
$418,127
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
miR-155 targeted therapeutics for precision medicine in lung cancer
|
1R01CA222007-01A1
|
$536,674
|
$536,674
|
CALIN, GEORGE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Therapeutic potential of antitumorigenic soluble MET variants induced by splicing interference
|
1R01CA219689-01A1
|
$372,340
|
$372,340
|
CARTEGNI, LUCA
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
Mechanisms of Chromosome Maintenance in Bacteria
|
ZIA BC 010277
|
$610,807
|
$61,081
|
Chattoraj, Dhruba
|
CCR (NCI)
|
|
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
|
7R01CA182528-06
|
$392,355
|
$392,355
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Metabolic reprogramming of Tregs in tumor immunity
|
5R01CA221290-02
|
$410,606
|
$205,303
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Clinical Scholars Biomedical Research Training Program
|
5T32CA009512-30
|
$394,664
|
$78,933
|
CHI, PING
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia
|
5R01CA196604-04
|
$354,563
|
$177,282
|
CHIANG, MARK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Telomere Biology
|
ZIA BC 011519
|
$1,187,757
|
$23,755
|
Cooper, Julia
|
CCR (NCI)
|
|
Lambda Genetic Networks and Lambda Red-Mediated Recombination
|
ZIA BC 010336
|
$1,175,337
|
$293,834
|
Court, Donald
|
CCR (NCI)
|
|
Novel targeted adenovirus
|
5R01CA211096-02
|
$348,844
|
$348,844
|
CURIEL, DAVID
|
WASHINGTON UNIVERSITY
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
5P01CA016038-44
|
$980,728
|
$127,495
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
SPORE in Genitourinary Cancer
|
3P50CA091846-15S1
|
$1,162,609
|
$116,261
|
DINNEY, COLIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Biomaterial approaches to attenuate macrophage recognition of self-signals from cancer cells
|
1F32CA228285-01
|
$58,654
|
$29,327
|
DOOLING, LAWRENCE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Mechanisms of tumor escape from anti-angiogenic therapy
|
5R01CA177875-06
|
$331,616
|
$165,808
|
DUDLEY, ANDREW
|
UNIVERSITY OF VIRGINIA
|
|
Insonation of ultrasound microbubbles at low frequency to enhance image-guided therapy
|
2R01CA112356-11A1
|
$402,443
|
$201,222
|
FERRARA, KATHERINE
|
STANFORD UNIVERSITY
|
|
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
|
3R01CA196947-03S1
|
$56,995
|
$56,995
|
FIGUEIREDO, MARXA
|
PURDUE UNIVERSITY
|
|
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
|
5R01CA196947-03
|
$349,968
|
$349,968
|
FIGUEIREDO, MARXA
|
PURDUE UNIVERSITY
|
|
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
|
5R35CA197452-04
|
$904,242
|
$904,242
|
FLORES, ELSA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Targeting epigenetic regulators using bacterial macromolecule delivery
|
5R01CA188382-05
|
$307,616
|
$307,616
|
FORBES, NEIL
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$546,995
|
$164,099
|
Fry, Terry
|
CCR (NCI)
|
|
Reporter Gene Technologies for Integrated Cancer Diagnostics
|
5R01CA082214-18
|
$375,250
|
$93,813
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
Mechanisms in Polyomavirus Assembly
|
5R01CA037667-34
|
$371,424
|
$92,856
|
GARCEA, ROBERT
|
UNIVERSITY OF COLORADO
|
|
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells
|
3R01CA181598-05S1
|
$100,813
|
$50,407
|
GILBOA, ELI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells
|
5R01CA181598-05
|
$318,513
|
$159,257
|
GILBOA, ELI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
|
1R01CA222804-01A1
|
$414,488
|
$414,488
|
GLORIOSO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Targeting melanoma hypoxia with lactic acid bacterium L. lactis
|
5R21CA210202-02
|
$167,475
|
$167,475
|
GOMEZ-GUTIERREZ, JORGE
|
UNIVERSITY OF LOUISVILLE
|
|
Exploiting the Context-Dependence of Notch to Develop Safer T-ALL therapy
|
1F30CA228228-01
|
$36,023
|
$18,012
|
GORMLEY, ANNA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$584,807
|
$116,961
|
Gottesman, Michael
|
CCR (NCI)
|
|
Liver Cancer Risk with rAAV Gene Therapy
|
5R01CA190144-04
|
$586,035
|
$586,035
|
GROMPE, MARKUS
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Mechanism, Regulation and Application of miRNA pathway in cancer
|
ZIA BC 011566
|
$815,028
|
$244,508
|
Gu, Shuo
|
CCR (NCI)
|
|
RNA Therapeutics for Targeted Treatment of Colon Cancer
|
5R01CA186100-05
|
$342,809
|
$342,809
|
GUO, BIN
|
UNIVERSITY OF HOUSTON
|
|
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors
|
5R01CA204968-03
|
$506,098
|
$506,098
|
HANES, JUSTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
Exploring the therapeutic potential and pathogenic contribution of MTAP deletion in Glioblastoma
|
5F30CA206336-02
|
$49,524
|
$49,524
|
HANSEN, LANDON
|
DUKE UNIVERSITY
|
|
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
|
5R01CA175318-04
|
$354,563
|
$354,563
|
HATEFI, ARASH
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
Efficient Delivery of Plasmid DNA to Achieve Appropriate Transgene Expression
|
5R01CA186730-04
|
$359,454
|
$359,454
|
HELLER, RICHARD
|
OLD DOMINION UNIVERSITY
|
|
DNA-specific pattern recognition receptor activation following DNA electroporation
|
5R01CA196796-03
|
$316,169
|
$158,085
|
HELLER, LOREE
|
OLD DOMINION UNIVERSITY
|
|
SPORE in Skin Cancer
|
5P50CA174523-05
|
$2,300,000
|
$92,000
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
Total relevant funding to Gene Therapy for this search: $35,380,030
|